Curcumin Endometrial Cancer - Curcumin Causes Death of Endometrial Cancer Cells
Written by Keith D. Bishop, Clinical Nutritionist, B.Sc. Pharmacy - Date: 02/04/2015
Curcumin inhibits the spreading and growth of human endometrial cancer cells.
In a laboratory cell study human endometrial cancer cells were exposed to curcumin for 12, 24 and 48 hours. Curcumin slowed the
growth (apoptosis) and spreading of the endometrial cancer cells. Higher curcumin doses and longer the exposure
time provided better cancer killing results.
At the date of publication there have not been any human endometrial cancer curcumin studies. So the dose necessary
to kill endometrial cancer in the human body is not known.
Curcumin is not well absorbed. Plain curcumin or curcumin extract is not well absorbed. Adding BioPerine (black
pepper extract) to curcumin appears to increase blood levels by 200-2,000%. CurcuPlex CR and DIMension 3 by Xymogen have both curcumin and BioPerine.
DIMension 3 also contains diindolylmethane (DIM). Diindolylmethane is also being researched in for use in
endometrial cancer and other estrogen driven cancers including breast cancer, prostate cancer, and ovarian cancer.
About the Author:
Keith D. Bishop, Clinical Nutritionist, B.Sc. Pharmacy (retired pharmacist), helps his clients improve their health
by using natural products, functional tests, diet, lifestyle and self-care. He writes special reports, consults and
gives seminars on natural product, diet and lifestyle effects on cancer. You may schedule an appointment for customized natural
cancer or alternative cancer recommendations by calling 405.919.1982.
European Journal of Gynecological Oncology. 2014;35(6):718-23. Curcumin promotes the apoptosis of human
endometrial carcinoma cells by downregulating the expression of androgen receptor through Wnt signal
pathway. Feng W1, Yang CX, et al.
Return from Curcumin
Endometrial Cancer to Natural Cancer News 2015